Profluent partners with Eli Lilly on AI-designed recombinases
The deal targets recombinases for genetic medicine.
Synthetic biologyprofluent.bio
StartupUS1 field
| Technology | ||
|---|---|---|
| Synthetic biologyUses protein language models to design gene editors such as the open-source OpenCRISPR-1. | Uses protein language models to design gene editors such as the open-source OpenCRISPR-1. | profluent.bio |
The deal targets recombinases for genetic medicine.
The paper describes OpenCRISPR-1, a gene editor generated by a protein language model.